|
|
|
Insider
Information: |
Gorman Kevin Charles |
Relationship: |
Director |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
517,112 |
|
Indirect Shares
|
57,996 |
|
|
Direct
Value |
$71,519,380 |
|
|
Indirect Value
|
$8,086,382 |
|
|
Total
Shares |
575,108 |
|
|
Total
Value |
$79,605,763 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
Percentage
Gain/Loss : |
17.5%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Neurocrine Biosciences Inc |
NBIX |
Chief Executive Office... |
2024-02-13 |
512,052 |
2004-09-22 |
57,996 |
Premium* |
|
Xencor Inc |
XNCR |
Director |
2024-02-13 |
5,060 |
2023-06-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
82 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NBIX |
Neurocrine Biosciences In... |
President and CEO |
|
2016-01-19 |
4 |
AS |
$46.70 |
$175,125 |
D/D |
(3,750) |
224,952 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
President and CEO |
|
2016-02-03 |
4 |
AS |
$38.04 |
$118,875 |
D/D |
(3,125) |
228,077 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
President and CEO |
|
2016-12-23 |
4 |
OE |
$2.59 |
$23,569 |
D/D |
9,100 |
237,177 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2017-01-10 |
4 |
AS |
$43.28 |
$162,300 |
D/D |
(3,750) |
240,927 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2017-01-17 |
4 |
AS |
$40.65 |
$152,438 |
D/D |
(3,750) |
244,677 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2017-02-03 |
4 |
AS |
$42.55 |
$132,969 |
D/D |
(3,125) |
247,802 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2017-02-06 |
4 |
AS |
$43.18 |
$129,972 |
D/D |
(3,010) |
250,542 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2017-02-08 |
4 |
OE |
$2.59 |
$166,177 |
D/D |
64,161 |
314,703 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2017-04-12 |
4 |
AS |
$50.41 |
$988,085 |
D/D |
(19,596) |
332,607 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2017-05-02 |
4 |
AS |
$53.23 |
$1,157,167 |
D/D |
(21,739) |
332,607 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2017-05-02 |
4 |
OE |
$2.59 |
$56,304 |
D/D |
21,739 |
354,346 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2018-01-16 |
4 |
AS |
$78.89 |
$295,820 |
D/D |
(3,750) |
336,357 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2018-02-05 |
4 |
AS |
$83.08 |
$498,164 |
D/D |
(5,983) |
342,874 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2018-02-06 |
4 |
D |
$82.48 |
$337,426 |
D/D |
(4,091) |
347,033 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2018-02-06 |
4 |
AS |
$80.07 |
$8,006,620 |
D/D |
(100,000) |
342,874 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2018-02-06 |
4 |
OE |
$5.76 |
$576,000 |
D/D |
100,000 |
442,874 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2018-05-01 |
4 |
OE |
$5.76 |
$730,552 |
D/D |
126,832 |
473,865 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2018-05-01 |
4 |
AS |
$80.75 |
$10,241,735 |
D/D |
(126,832) |
347,033 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2018-06-28 |
4 |
OE |
$5.76 |
$533,416 |
D/D |
57,924 |
404,957 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2019-02-04 |
4 |
AS |
$88.10 |
$275,321 |
D/D |
(3,125) |
408,082 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2019-02-05 |
4 |
AS |
$88.12 |
$395,895 |
D/D |
(4,489) |
413,943 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2019-02-06 |
4 |
AS |
$84.23 |
$344,986 |
D/D |
(4,096) |
417,597 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2019-08-06 |
4 |
AS |
$95.15 |
$4,844,380 |
D/D |
(50,911) |
417,597 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2019-08-06 |
4 |
OE |
$8.66 |
$440,889 |
D/D |
50,911 |
468,508 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2019-08-07 |
4 |
AS |
$95.12 |
$262,440 |
D/D |
(2,759) |
417,597 |
0 |
- |
|
82 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|